AzTrials
AzTrials

Anorectal MalformationMARQOLNCT02029248

National Study on the Quality of Life of Patients With Anorectal Malformation

An observational study of Anorectal Malformation, run by Nantes University Hospital at 37 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Anorectal malformations, occurring approximately 1 in 5000 live births, mainly involve the distal anus and rectum, but also sometimes the urinary and genital tracts. Defects range from the minor and easily treated with an excellent functional prognosis, to those that are complex and often associated with a poor… Read more about this study

Who is it for?
Ages 6 to 30 years
Conditions the study is for
Anorectal Malformation
What is being tested?
Quality of life questionnaire
How many people
762 participants
Where
37 sitesFrance
Study dates
Apr 2012to Apr 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 30 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Patients initially treated in a french pediatric surgery service for anorectal malformation

Who may be able to join

  • Patients who are between 6 and 30 years old
  • Patients initially treated in a french pediatric surgery service for anorectal malformation

Who cannot join

  • Patients lost from sight or dead
  • Patients with concomitant malformations that can modify sphincter functions besides anorectal malformation (spina bifida, )
  • Patients whose brain functions do not allow to reply to a questionnaire (mental retardation)

Trial locations and contacts

37 sites in 1 country.

37 sites in 1 country

France37 sites
  • CHU Amiens

    Amiens, 80054

  • CHU Angers

    Angers, 49033

  • CHU Besançon

    Besançon, 25030

  • CHU Bordeaux

    Bordeaux, 33076

  • CHU Brest

    Brest, 29609

  • Hospices Civils de Lyon

    Bron, 69677

  • CHU Caen

    Caen, 14033

  • CHU Clermont-Ferrand

    Clermont-Ferrand, 63000

  • Hôpitaux Civils de Colmar

    Colmar, 68024

  • CHU Dijon

    Dijon, 21079

  • CHU Fort-de-France

    Fort-de-France (Martinique), 97261

  • CHU Grenoble

    Grenoble, 38043

  • AP-HP Hôpital Bicêtre

    Le Kremlin-Bicêtre, 94275

  • CH Le Mans

    Le Mans, 72037

  • CHRU Lille

    Lille, 59037

  • CHU Limoges

    Limoges, 87042

  • AP-HM La Timone

    Marseille, 13385

  • AP-HM Hôpital Nord

    Marseille, 13915

  • CHU Montpellier

    Montpellier, 34295

  • CHU de Nantes

    Nantes, 44093

  • CHU Nice

    Nice, 06200

  • CHR Orléans

    Orléans, 45032

  • AP-HP Hôpital Trousseau

    Paris, 75012

  • AP-HP Hôpital Necker

    Paris, 75015

  • AP-HP Hôpital Robert Debré

    Paris, 75019

  • CHU Pointe-à-Pitre

    Pointe-à-Pitre (Guadeloupe), 97159

  • CHU Poitiers

    Poitiers, 86021

  • CHU Reims

    Reims, 51100

  • CHU Rennes

    Rennes, 35203

  • CHU Rouen

    Rouen, 76031

  • CHR La Réunion

    Saint Denis (La Réunion), 97405

  • CH Saint Brieuc

    Saint-Brieuc, 22027

  • CHU Saint Etienne

    Saint-Etienne, 42055

  • CHRU Strasbourg

    Strasbourg, 67098

  • CHU Toulouse

    Toulouse, 31059

  • CHRU Tours

    Tours, 37044

  • CHU Nancy

    Vandœuvre-lès-Nancy, 54511

Other trials in France

About this study

Official title: National Study on the Quality of Life of Patients With Anorectal Malformation (MARQOL)

Anorectal malformations, occurring approximately 1 in 5000 live births, mainly involve the distal anus and rectum, but also sometimes the urinary and genital tracts. Defects range from the minor and easily treated with an excellent functional prognosis, to those that are complex and often associated with a poor functional prognosis.

Despite the better knowledge of the anatomy and physiology and the improvement of surgical management after birth, fecal and urinary incontinence can occur, due mainly to deficient nerve supply.

The quality of life of such patients is largely unknown in this country. The aim of the investigators study is to propose specific and generic questionnaires to the patients registered in the national database, correlated to their anatomical and functional status. A better understanding of such correlations should allow improvements in their medical and social management.

Read the detailed description

Anorectal malformations (ARM), occurring approximately 1 in 5000 live births, mainly involve the distal anus and rectum, but also sometimes the urinary and genital tracts. Defects range from the minor and easily treated with an excellent functional prognosis, to those that are complex and often associated with a poor functional prognosis. Despite the better knowledge of the anatomy and physiology and the improvement of surgical management after birth, fecal and urinary incontinence can occur, due mainly to deficient nerve supply. A few studies and clinical practice have shown that disease-specific problems of ARM have an effect on somatic function, mental health and psychosocial functioning.

The assessment of quality of life requires a self-report questionnaire composed of items related to physical, emotional and social functioning, and disease-related symptoms. A specific ARM questionnaire, the HAQL, was developed by a Dutch team and published in 2001. Associated with generic questionnaire, it allowed quality of life assessment in Dutch population.

The quality of life of such patients is largely unknown in this larger country. The aim of the investigators study is to propose specific (HAQL translated from Dutch to French) and generic questionnaires to the patients registered in the national database, correlated to their anatomical and functional status.

A better understanding of such correlations should allow improvements in their medical and social management.

Being tested
Quality of life questionnaire
Keywords
Anorectal malformation, fecal incontinence, quality of life, child
Medical subject headings
Anorectal Malformations, Fecal Incontinence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quality of life questionnaireOther

Study groups in NCT02029248
Study groupRoleWhat they receive
Children 6-7Patients who are between 6 and 7 years old
Receives: Other: Quality of life questionnaire
Children 8-11Patients who are between 8 and 11 years old
Receives: Other: Quality of life questionnaire
Children 12-16Patients who are between 12 and 16 years old
Receives: Other: Quality of life questionnaire
Patients 17-30Patients who are between 17 and 30 years old
Receives: Other: Quality of life questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of life measured by HAQL specific questionnaire and two generic questionnaires: VSPA for children or WHOQOL-BREF for adults; functional status measured by Krickenbeck score

    HAQL: between 35 and 48 items (depending on the age of the patients) composing 8 dimensions; VSPA: 39 items composing 8 dimensions; WHOQOL-BREF: 26 items composing 4 dimensions; Krickenbeck: 3 items.

    Measured: At the time of the inclusion

Secondary outcomes (1)
  1. Kind of malformation, associated malformation, sequelas, handicap degree, social integration

    Clinical questionnaire

    Measured: At the time of the inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2014 (estimated)
  2. Study startApr 2012
  3. Primary completionApr 2015
  4. Study completionApr 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
762 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02029248
Sponsor's protocol ID
BRD/10/06-R
Acronym
MARQOL
Status last verified
Jul 2017
First submitted
2 Dec 2013
Last updated
19 Jul 2017
Results posted
No
Data monitoring committee
No

Publications

  • Clermidi P, Podevin G, Cretolle C, Sarnacki S, Hardouin JB. The challenge of measuring quality of life in children with Hirschsprung's disease or anorectal malformation. J Pediatr Surg. 2013 Oct;48(10):2118-27. doi: 10.1016/j.jpedsurg.2013.03.071.

    PubMed 24094967
  • Mantoo S, Meurette G, Wyart V, Hardouin J, Cretolle C, Capito C, Sarnacki S, Podevin G, Lehur PA. The impact of anorectal malformations on anorectal function and social integration in adulthood: report from a national database. Colorectal Dis. 2013 Jun;15(6):e330-5. doi: 10.1111/codi.12186.

    PubMed 23464709
  • Podevin G, Petit T, Mure PY, Gelas T, Demarche M, Allal H, Becmeur F, Varlet F, Philippe P, Weil D, Heloury Y. Minimally invasive surgery for anorectal malformation in boys: a multicenter study. J Laparoendosc Adv Surg Tech A. 2009 Apr;19 Suppl 1:S233-5. doi: 10.1089/lap.2008.0137.supp.

    PubMed 18973467
  • Fleury J, Picherot G, Cretolle C, Podevin G, David A, Caillon J, Roze JC, Gras-le Guen C. Currarino syndrome as an etiology of a neonatal Escherichia coli meningitis. J Perinatol. 2007 Sep;27(9):589-91. doi: 10.1038/sj.jp.7211783.

    PubMed 17724455

Questions about this trial

What is this clinical trial studying?

An observational study of Anorectal Malformation, run by Nantes University Hospital at 37 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 37 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of life measured by HAQL specific questionnaire and two generic questionnaires: VSPA for children or WHOQOL-BREF for adults; functional status measured by Krickenbeck score (time frame: At the time of the inclusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02029248, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in